Jonathan McNeill

Insider Reports History

Location
Waltham, MA
Signature
/s/ Barbara Bispham, as attorney-in-fact for Jonathan McNeill
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jonathan McNeill:

Company Role Class Num Shares Value Price $ Report Date Ownership
Dyne Therapeutics, Inc. Chief Business Officer Common Stock 132,106 $6,076,876 $46 19 Aug 2024 Direct
CRESCENT BIOPHARMA, INC. President and COO Ordinary Shares 134,200 $33,550 $0.25 13 Jun 2025 Direct
CRESCENT BIOPHARMA, INC. President and COO Stock Option (Right to Buy) 172,836 08 Dec 2025 Direct
Dyne Therapeutics, Inc. Chief Business Officer Stock option (right to buy) 0 11 Mar 2024 Direct

Insider Reports Filed by Jonathan McNeill

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CBIO CRESCENT BIOPHARMA, INC. 08 Dec 2025 1 $0 4 President and COO 10 Dec 2025, 16:37
CBIO GLYCOMIMETICS INC 13 Jun 2025 0 $0 3 Chief Operating Officer and President. Exhibit 24 - Power of Attorney 23 Jun 2025, 18:27
DYN Dyne Therapeutics, Inc. 19 Aug 2024 2 -$122,054 4 Chief Business Officer 20 Aug 2024, 16:27
DYN Dyne Therapeutics, Inc. 11 Jun 2024 1 -$57,132 4 Chief Business Officer 11 Jun 2024, 19:34
DYN Dyne Therapeutics, Inc. 16 May 2024 2 -$78,419 4 Chief Business Officer 17 May 2024, 21:03
DYN Dyne Therapeutics, Inc. 08 Mar 2024 11 -$2,264,022 4 Chief Business Officer 13 Mar 2024, 06:04
DYN Dyne Therapeutics, Inc. 07 Mar 2024 1 -$62,918 4 Chief Business Officer 11 Mar 2024, 21:50
DYN Dyne Therapeutics, Inc. 29 Feb 2024 8 -$791,039 4 Chief Business Officer 01 Mar 2024, 21:37
DYN Dyne Therapeutics, Inc. 26 Jan 2024 4 -$475,910 4 Chief Business Officer 26 Jan 2024, 19:48
DYN Dyne Therapeutics, Inc. 02 Jan 2024 8 -$514,594 4 Chief Business Officer 04 Jan 2024, 21:47
DYN Dyne Therapeutics, Inc. 11 Dec 2023 1 -$13,346 4 Chief Business Officer 12 Dec 2023, 17:34
DYN Dyne Therapeutics, Inc. 15 Nov 2023 2 $0 4 Chief Business Officer 16 Nov 2023, 16:34
DYN Dyne Therapeutics, Inc. 18 Sep 2023 1 -$11,866 4 Chief Business Officer 20 Sep 2023, 17:49
DYN Dyne Therapeutics, Inc. 12 Sep 2023 1 -$13,179 4 Chief Business Officer 13 Sep 2023, 20:53
DYN Dyne Therapeutics, Inc. 11 Jul 2023 1 $0 4 Chief Business Officer 04 Apr 2024, 21:06
DYN Dyne Therapeutics, Inc. 12 Jun 2023 2 -$28,649 4 Senior Vice President of Business Development 14 Jun 2023, 18:40
DYN Dyne Therapeutics, Inc. 13 Mar 2023 2 -$29,115 4 Senior Vice President of Business Development 15 Mar 2023, 17:50
DYN Dyne Therapeutics, Inc. 18 Jan 2023 3 -$133,000 4 Senior Vice President of Business Development 23 Jan 2023, 07:27
DYN Dyne Therapeutics, Inc. 09 Jan 2023 1 -$348,835 4 Senior Vice President of Business Development 11 Jan 2023, 15:56
DYN Dyne Therapeutics, Inc. 09 Dec 2022 3 -$5,130 4 Senior Vice President of Business Development 13 Dec 2022, 16:05
DYN Dyne Therapeutics, Inc. 20 Sep 2022 1 -$17,070 4 Senior Vice President of Business Development 21 Sep 2022, 16:08
DYN Dyne Therapeutics, Inc. 15 Sep 2022 1 -$6,940 4 Senior Vice President of Business Development 15 Sep 2022, 17:27
DYN Dyne Therapeutics, Inc. 05 Jul 2022 1 $0 4 Senior Vice President of Business Development 06 Jul 2022, 18:21
DYN Dyne Therapeutics, Inc. 14 Jun 2022 1 -$2,494 4 Senior Vice President of Business Development 15 Jun 2022, 20:04
DYN Dyne Therapeutics, Inc. 11 Mar 2022 1 -$4,199 4 Senior Vice President of Business Development 14 Mar 2022, 17:09
DYN Dyne Therapeutics, Inc. 10 Dec 2021 2 $0 4 Senior Vice President of Business Development 14 Dec 2021, 15:22
DYN Dyne Therapeutics, Inc. 20 Sep 2021 2 -$20,251 4 Senior Vice President of Business Development 22 Sep 2021, 20:02
DYN Dyne Therapeutics, Inc. 10 Jul 2021 1 $0 4 Senior Vice President of Business Development 13 Jul 2021, 16:22